Hjem › Uveal melanom › New York
Kliniske studier for Uveal melanom i New York
7 studier for Uveal melanom søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT05607095Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Memorial Sloan Kettering Cancer Center, New York
- Northwell Health, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07804186Adjuvant Tebentafusp in High Risk Ocular Melanoma
- Northwell Health -Center for Advanced Medicine, Lake Success
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jun. 2026 · NCT06246149ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
- Northwell Health Cancer Institute, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2/3
Alle aldre · Alle kjønn · Oppdatert 2. apr. 2026 · NCT06581406Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Northwell Health Center for Advanced Medicine, New Hyde Park
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 4. des. 2025 · NCT06121180Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.